Nusirt
Biotechnology company focused on developing products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | $2.0m | Seed | |
| Total Funding | 000k | ||
Related Content
NuSirt Biopharma, Inc. is a pioneering biotech company that has developed a unique technology platform integrating natural compounds with pharmaceutical agents. This innovative approach is protected by an extensive intellectual property (IP) portfolio, which includes thirteen issued or allowed patents and several pending globally. The company has successfully validated its technology through multiple clinical studies, demonstrating its potential in treating various metabolic disorders, including Type 2 Diabetes. NuSirt operates in the biopharmaceutical market, primarily serving healthcare providers and patients seeking advanced treatment options. The business model revolves around the development and commercialization of its proprietary technology, generating revenue through licensing agreements, partnerships, and direct sales of its therapeutic solutions.
Keywords: biotech, natural compounds, pharmaceutical agents, IP portfolio, clinical studies, metabolic disorders, Type 2 Diabetes, healthcare, licensing, commercialization.